NICE guidance on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma. Issue 10 (October 2022) - Adler, Amanda I; Slayen, Samuel; Stegenga, Heather; Guo, Yelan; Diaz, Richard; Welton, Nicky J; Westwood, Nigel; Doull, Iolo; Crawley, Charles